
501 - 1000 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that develops RNA interference (RNAi)-based therapeutics to silence disease-causing genes and treat intractable, often intractable, cardiometabolic and pulmonary disorders. Using a portfolio of RNA chemistries and delivery technologies, Arrowhead aims to induce rapid, deep, and durable knockdown of target genes to address conditions such as hypertriglyceridemia, dyslipidemia, cardiovascular disease, and various pulmonary diseases.
Selected: 🇨🇦 Canada – Remote.
Selected: 🆕 Date Added.
🕒 August 18
Cardiometabolic Medical Science Liaison advancing Arrowhead Pharmaceuticals’ RNAi medicines. Engaging healthcare professionals, supporting trials, and communicating clinical science from Canada.